Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2016
December 2016, Vol 6, No 12
December 2016, Vol 6, No 12
Oncology Staff Need a Space to Grieve, Too
By
Meg Barbor, MPH
Read More ›
Financial Incentives for 340B Drugs Lead to Excess Chemotherapy Use, Increased Cost of Care
By
Wayne Kuznar
Reimbursement
The site of cancer care has dramatically drifted away from community oncology practices, but innovation in the form of payment reform and the oncology medical home is being driven by community oncology practices, according to Ted Okon, MBA, Executive Director, Community Oncology Alliance.
Read More ›
The Oncology Care Model: Aligning Financial Incentives to Improve Outcomes
By
Maharshi Patel, BS, MBA, COO
Practice Management
Read More ›
Leveraging Financial Advocates to Improve Patient Care
By
Meg Barbor, MPH
Read More ›
Physician Dispensing Oral Drugs Networks Win, for Now, but Don’t Drop Your Guard
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›
Making the Patient Part of the Clinical Conversation
By
Meg Barbor, MPH
Read More ›
The “Hotspotters” Driving Up the Costs of Cancer Care
By
Meg Barbor, MPH
Read More ›
Medications Used for the Treatment of Bladder Cancer and the Associated ICD-10 Codes
By
Kristin A. Esposito, CPhT
ICD Codes
,
Cancer Drug Coding
,
Reimbursement
Read More ›
Select Ongoing Trials Currently Enrolling Patients with Bladder Cancer
Clinical Trials Tracker
,
Clinical Trials Tracker
The following clinical trials represent a selection of key studies that are currently recruiting patients with bladder cancer for inclusion in investigations of new therapies and new regimens of existing treatments for patients with bladder cancer.
Read More ›
Certain Measures Can Lower the High Cost of USP 800 Compliance
By
Meg Barbor, MPH
Read More ›
Page 1 of 2
1
2
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Out Models Cost Patients and Employers More Than They Disclose
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
By
Marianne Davies, DNP, ACNP, AOCNP, FAAN
;
Shawn Perkins, RN, BSN, OCN
3.
Dexamethasone-Sparing Regimen Safe and Effective in Frail Patients with Multiple Myeloma
By
William King
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes